marginal significanceP=0.060
An LRP reversing agent, PAK-104P, was found to increase the daunorubicin content with marginal significance (P=0.060).
An LRP reversing agent, PAK-104P, was found to increase the daunorubicin content with marginal significance (P=0.060).